Tempest Therapeutics
Tempest is a California-based clinical-stage oncology company that researches and develops immune-mediated small molecule therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Tempest Therapeutics Information
Geographic Data
Address: 7000 Shoreline Court
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$15M
Raised Total:$90M
Social
Metrics
4,115,746Website Global Rank
2,933Website Monthly Traffic
Twitter Followers
Description
Tempest is a California-based clinical-stage oncology company that researches and develops immune-mediated small molecule therapeutics for the treatment of cancer.
Contact Phone:
+14157988589
Contact Email:
Tempest Therapeutics went public on 6/28/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/28/2021
Ticker Symbol:
TPST
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2011 | Venture Round | $5M | 2/2018 | Series B | $83.2M |
Versant Ventures F-Prime Capital Partners Lilly Asia Ventures Foresite Capital Eight Roads Ventures |
4/2022 | Post-IPO Equity | $0 |
EcoR1 Capital Versant Ventures EcoR1 Capital Versant Ventures |
6/2021 | PIPE | $30M |
Versant Ventures Rock Springs Capital F-Prime Capital Monashee Investment Management Quan Capital Lyfe Capital Maven Investment Partners US Lilly Asia Ventures Eight Roads Ventures |
3/2018 | Series B | 6 | $70M |
Eight Roads Ventures F-Prime Capital Foresite Capital Lilly Asia Ventures Quan Capital Versant Ventures Eight Roads Ventures F-Prime Capital Foresite Capital Lilly Asia Ventures Quan Capital Versant Ventures |
4/2022 | PIPE | 2 | $15M |
EcoR1 Capital Versant Ventures |
1/2021 | Debt | $15M |
Oxford Finance Oxford Finance |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2021 | Millendo Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
